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The child affected by a malformative syndrome represents a care challenge for the pediatrician. He is in fact the heart of the 
multidisciplinary team that has to manage the patient, trying to control the complications of his/her syndrome and promoting 
the correct psychophysical development. What we must not forget is that the pediatrician provides a continuous support to the 
child’s family, assisting them from the diagnosis to the management of problems related to the syndrome. This encourages the 
continuous follow-up of these children remembering also that the pediatrician is fundamental in the clinical management of the 
syndrome and for facilitating the social integration of these children. Biomed Rev 2018; 29: 37-46 
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INTRODUCTION
A birth defect, also known as a congenital disorder, is a con-
dition present at birth regardless of its cause. Birth defects 
may result in disabilities that may be physical, intellectual, 
or developmental. The disabilities can range from mild 
to severe. The prevalence of birth defects is about 2-4% 
among live births (1, 2) which is the equivalent of about 
one patient out of 200 children with complex malformative 
syndromes and they are singularly considered rare diseases 
(3). It is calculated that the complex malformative syndromes 
are approximately 8000, about a hundred of which have a 
prevalence between 1:2000 and 1:10.000; about 250 between 
1:10.000 and 1:100.000, and about one thousand up to 1:1 
million (4). The remaining 6500 represent sporadic cases. 
Therefore, because of the common genetic origin (80% of 
the cases), of the manifestation in pediatric age and the con-
comitant association with a form of disability, the complex 
malformative syndromes represent an important problem of 
public health (5, 6).
R e v i e w
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Table 1. 
SYNDROME PREVALENCE SYNDROME PREVALENCE
Down 1/800 Prader Willi 1/10.000
Klinefelter 1/1.200 Trisomy 13 1/10.000
Fra-X 1/2.000 Angelman 1/12.000
Noonan 1/2.000 Beckwith 1/14.000
Neurofibromatosis 1 1/3.000 Achondroplasia 1/15.000
Del22 (DiGeorge) 1/3.000 Williams 1/20.000
Trisomy 18 1/5.000 Saethre Chotzen 1/25.000
Turner 1/5.000 Poland 1/30.000
Tuberous sclerosis 1/5.800 Kabuki 1/32.000 (Jap)
VATER 1/7.000 Smith Lemli Opitz 1/40.000
Arthogryposis multipla 1/10.000 Wolf 1/50.000
CHARGE 1/10.000 Apert 1/70.000
De Lange 1/10.000 Crouzon 1/80.000
Spondilocostal dysostosis 1/10.000 Cohen 1/100.000
Ehlers-Danlos 1/25.000 Holt Oram 1/100.000
Marfan 1/10.000 Sotos 1/10.000
Indeed, in Italy the period which goes from 0 to 18 years, 
age known as childhood-adolescence, includes roughly 10 
million people. The 15 % of which, equivalent to 1.5 million, 
is represented by “children with special needs”, affected by 
chronic diseases which require a very demanding medical ap-
proach (7). Among this group of patients, about half (8% of 
the total, equal to 800.000 patients) are affected by diseases 
that involve disabilities, mental and physical defects that pre-
vent social participation. These disabilities include different 
conditions such as: autism, infant cerebral palsy, consequence 
of tumors, but also diseases with elevated assistance demands 
the 0.5% of cases, equal to 50.000 patients, malformative syn-
dromes like: Down, Cornelia de Lange and Noonan syndromes 
(8–10). These diseases can involve very serious clinical prob-
lems preventing personal autonomy, with important effects on 
assistance and social life. Hence in Italy in the last few years it 
was necessary to develop the branch of “Pediatrics of disabil-
ity” which doesn’t only involve the multispecialized medical 
approach, but is enhanced by multisectorial approaches which 
includes educational, scholastic and social features extended to 
the whole territory (11). Such an approach should be achieved 
through the creation of an assistance network which should 
integrate the reference group for rare diseases, which should 
create the assistance program and the family pediatrician, who 
should participate to the whole program (4). 
What is the role of the family pediatrician in this integrated 
assistance network? For sure it’s a fundamental and compre-
hensive role, which goes from the possibility of suspecting 
a disease to the management of its clinical requirements in 
collaboration with the reference group. In addition, the fam-
ily pediatrician should identify the social needs of the child, 
understand the emergency and report the cases that need a 
rehabilitation (12, 13). 
In other words, he could be the person responsible for the 
territory, who works in close touch with the family to facilitate 
the access to all the medical and social services (4).  These 
services should completely satisfy the needs of the child and 
his family to facilitate the participation of the child to the social 
life in the best way possible (13). 
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THE PEDIATRICIAN MEETS THE CHILD WITH A 
MALFORMATIVE SYNDROME
The pediatrician can do this in several ways:
1 When, among his patients, the pediatrician meets a newborn 
a label, apart from the physical problems associated with 
genetic syndromes. Among these there are the fear that the 
child will be discriminated because of his condition and the 
-
ents (13). Other important aspects are: the prognosis 
vitam and , the implementation of an 
assistance program, the genetic consultation to investigate 
contact with a parent’s association to receive psychological 
support (4). Therefore, it’s important that the pediatrician 
acquires as much information on the condition of the child 
especially on the variation of the medical situation, possible 
complications and follow-up (14). It would be useful to 
make sure the family has correctly understood the disease of 
the child and if not the pediatrician should refer the parents 
to the center which drew up the diagnosis (4). It would be 
also useful for the doctor to carry out a careful pediatric 
examination in order to treat the child like a normal patient, 
having periodic evaluations of height’s and weight’s growth 
syndrome. It would be wise to introduce a correct diet, for 
example hypocaloric in the Prader-Willi syndrome and 
hyper caloric in the Costello syndrome, and propose the 
optional vaccinations which don’t have side effects from 
the beginning (15, 16). In fact, vaccinations are quite use-
ful considering the high risk of respiratory infections in 
children with congenital heart disease, dysphagia/gastro-
ribs abnormalities (17). The pediatrician must constantly 
follow in which way the family tackles the problem and the 
2 When the newborn arrives without a diagnosis, but instead 
with one or more major malformations (18–20). The pediatri-
-
tion of the disease, knowing that even without a diagnostic 
label, the single problems can be faced in the same way. 
3 When a normal child begins to show abnormalities in the 
psychomotor development or growth problems. The pedia-
trician should understand if the abnormality is isolated or 
associated with other malformations (21). For this reason, 
it’s important that he prescribes blood test, radiological 
studies and functional tests like electroencephalogram, 
electrocardiogram, audiometric and oculist examination 
to reveal possible problems.
4 When he himself draws up the diagnosis of malformations or 
functional problems (visual, auditory, neurological, cardiac, 
renal) after the neonatal period. He should also document 
the clinical problems and his own diagnostic suspicion, di-
recting the child to the geneticist. Apart from this he should 
explain why is sending the child to the geneticist and the 
possible diagnostic process (18, 20, 22–26). At this point the 
pediatrician should inform the parents about the limits of the 
diagnostic process, in fact his suspicion could be erroneous 
or else it isn’t possible to draw up a perfect diagnosis (13). 
WHEN AND HOW CAN THE SYNDROME BE SUSPECTED
The clinical approach to the malformation syndromes presents 
peculiarities because of the clinical, etiological and patho-
suspicion which precedes the clinical analysis, but demands 
especially attention on the part of the pediatrician (18). 
The clinical elements which led to suspect a malformation 
syndrome are four: the presence of facial dysmorphisms such 
as hypertelorism, proptosis, oblique rima palpebrarum upwards 
or downwards, short nose with antiverse nostrils, long philtrum 
micrognathia and ears in a lower position (18). These details 
give the face a very particular aspect, in fact these patients 
don’t resemble any member of the family.
The presence of major or minor malformations variably 
associated between themselves (18). In fact, an anorectal ab-
normality is syndromic in 50% of the cases, the cleft palate in 
the 30%, an heart congenital disease or cataract in the 20% and 
a kidney malformation in the 15% (27). Some malformations 
in the oro-facial-digital syndrome, the pulmonary stenosis 
valve in Noonan syndrome, the stenosis above aortic valve 
and the stenosis of pulmonary arteries in Williams syndrome, 
an heart disease and cleft palate in DiGeorge syndrome and 
the duodenal stenosis in Down syndrome (8, 10). 
The presence of growth problems, either in excess (gi-
between head and torso, torso and limbs, between the limbs 
themselves or between hemisomes (28). The abnormalities can 
also involve the skull such as macrocephaly (Sotos syndrome, 
hydrocephalous), and microcephaly which is evident at birth as 
in the Fetal Alcohol Spectrum Disorders (FASD; see Carito et 
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al’s “FASD in Pediatrics” in this volume of Biomedical Reviews) 
or in the Seckel syndrome, or else this can appear at a later period 
as in the Angelmann syndrome or in the Rett syndrome (29–32). 
The presence of delayed psychomotor development, es-
pecially if associated with sensorial problems, is probably 
linked to a syndrome (21). If congenital abnormalities ap-
pear at birth it’s the job of the neonatologist to assess them, 
but after that it will be responsibility of the pediatrician 
to identify defects in psychomotor development (33). The 
pediatrician will have also to consider major malformations 
in a child appearing normal at birth or else if the child had 
only one single malformation. Indeed, it is important that 
associated with a syndrome.
Then it will be the geneticist job to understand the etiology 
of the syndrome throughout a process composed of various 
elements which tend to complement each other, but which 
can also lead to diagnosis if considered separately. Therefore, 
there are two roads to follow in order to reach the diagnosis: 
the gestalt
one, at a glance, consists in the immediate recognition of a 
between memory and experience like recognizing a friend 
among a crowd. The diagnostic suspicion must then be con-
The analytical diagnosis, instead, uses the classical medi-
cal instruments such as: the family’s history (genealogical 
tree of at least three generation to identify genetic diseases), 
the gestational history (threat abortion, quantity of amniotic 
of alcohol and drugs, tobacco, prenatal diagnosis), neonatal 
history (asphyxia), physical examination, instrumental and 
clinical analyses associated to computer systems (POSSUM 
scoring system, London Dysmorphology Database) (21, 34).
-
are compatible with the disease, and prescribing genetic tests. 
The recent development of genetic testing, with an estimated 
detection rate of 40% for Next Generation Sequencing (NGS) 
and of 10% for microarrays analyses, allows to perform an 
etiological diagnosis in at least half of the known syndromes: 
Williams syndrome 95%, Sotos syndrome 90%, Noonan syn-
drome 80%, Cornelia de Lange syndrome, Kabuki syndrome 
and CHARGE syndrome 70%. (9, 10, 29, 35–37). 
SYNDROME OR ASSOCIATION MAIN SYMPTOMS GENETIC MUTATION
Achondroplasia
Poor growth with short arts, brachydactyly, 
macrocephaly, and facial dysmorphisms
Genetic mutation in the FGFR3 in 4p16.3
Neurofibromatosis 1
Cafe-au-lait spots, eye hamartomas (Lisch nodules), 
neurofibromas, skeletal abnormalities, optic nerve glioma
Mutation or deletion in the NF1 gene in 
17q11.2
 Angelman 
Facial dysmorphisms, microcephaly, developmental delay, 
language’s problems, epilepsy
Lack of function of 15q11.2 inherited from 
mother
Apert 
Craniosynostosis, facial dysmorphisms, syndactyly of 
hands and foot
Mutation in the FGFR2 gene in 10q26.13
Bardet Biedl
Obesity, mental disability, polydactyly post-axial, 
nephropathy, hypogonadism, retinopathy
Mutations in 12 different genes
Beckwith Wiedemann
Overgrowth, umbilical hernia, omphalocele, 
macroglossia, hemihyperplasia, visceromegaly
Mutation or deletion of imprinted 
genes in the area 11p15.5 
(H19,KCNQ10T1,CDKN1C)
Crouzon Craniosynostosis, facial dysmorphisms Mutation in the FGFR2 gene in 10q26.13
Marfan 
Above height and disproportionately long limbs 
(dolichostenomelia), ectopia lentis, aortic aneurysm or 
dilatation, mitral valve prolapse 
Mutation in the FBN1 gene in 15q21.1
Table 2. The clinical and genetic characteristics of the most common genetic syndromes (7, 8, 13, 23, 25, 29, 31–46).
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SYNDROME OR ASSOCIATION MAIN SYMPTOMS GENETIC MUTATION
Prader-Willi 
Facial dysmorphisms, hypotonia, small hands and foot, 
hypogonadism, obesity, hyperphagia, short stature, 
neurodevelopmental delays
Lack of function of 15q11.2 inherited from 
father
Rubistein-Taybi 
Facial dysmorphisms, growth’s problems, 
neurodevelopmental delays, wide and bifid thumbs or 
toes 
Microdeletion in the 16p13.3 area, and 
mutation in the CBBP gene in 16p13.3, 
mutation in the EP300 gene in 22q13
Sotos 
Overgrowth, increased bone age, facial dysmorphisms, 
delayed psychomotor development
Mutation or deletion in the NSD1 gene in 
the area 5q35 in (70% of patients)
Cri du chat Microcephaly and mental disability Deletion of a part of 5p
CHARGE 
Coloboma, congenital heart diseases, Choanal atresia/
stenosis, lack of growth, genitals abnormalities, 
hypoacusis, auricle abnormalities
Mutation in the CHD7 gene in 7q21.11, 
mutation in the  SEMA3E gene in 
8q12.1-q12.2
Cornelia De Lange 
Facial dysmorphisms, lack of growth, 
neurodevelopmental delays, hirsutism, small hands and 
foot
Mutation in the NIBL gene in 5p13.1, 
mutation in the SMC1L1 gene in 
Xp11.22-p11.21, mutation in the SMC3 
gene in 10q25
Di George 
Facial dysmorphisms, congenital heart disease, 
hypocalcaemia, immune deficiency, neurodevelopmental 
delays, cleft palate, suction’s and swallowing’s difficulties
Microdeletion of 22q11.2
Holt-Oram 
Heart congenital diseases (or ECG abnormalities), 
abnormalities of unilateral upper limb 
Mutation in the TBX5 gene in 12q24.21 
(30% of patients)
Noonan 
Facial dysmorphisms, short height, pulmonary stenosis, 
pterigium colli, pectus excavatum/carenatum
Mutation in the PTPN11 gene in 12q24.1 
(50% of patients), mutation of RAS-
MAPK’s pathway (KRASS, SOS1, NRAS, 
RAF1 genes)
Silver Russell 
Poor growth, asymmetry of limbs and face, facial 
dysmorphisms, disproportion between braincase and 
facial skeleton
Maternal upd (uniparental disomy) of 
chromosome 7 in the 10% patients, 
hypometilation of H19 gene in 11p15 
(30% of patients)
Treacher Collins Facial dysmorphism, variability of clinical signs
Mutation in the gene TCOF1 in 
5q32-q33.1, mutation in the gene POLR1C 
in 6p21.1, mutation in the gene POLR1D 
in 13q12.2
Williams 




Facial dysmorphism, short growth, neurodevelopmental 
delays, eyes, renal and neurological malformations
Deletion of 4p16.3
Goldenhar 
Asymmetry of the face, microtia or unilateral abnormality 
of the auricle, preauricular appendages, epibulbar 
dermoid and vertebral abnormalities
Clinical diagnosis
VATER/VACTERL
Vertebral and anal abnormalities, esophageal atresia 
associated to tracheo-esophageal fistula, renal 
malformations, heart congenital malformation
Clinical diagnosis
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THE ASSISTANCE AFTER THE DIAGNOSIS
Immediately after the establishment of a diagnosis, etiologi-
cal or genetic, or even in the absence of this the doctor takes 
control of the syndromic child; starting from the evaluation 
of his initial abilities (functional diagnosis) (53). At this point 
the pediatrician asks himself what the child will be able to 
do? What he will be able to do if he is helped? What can be 
corrected? What can be foreseen? All this to program the best 
clinical and rehabilitation follow-up (12). “The work of the 
pediatrician should come out of the clinic and be extended 
to all which is connected to the child’s life” (54). Therefore 
he can intervene on the child, but he must also consider the 
economic, environmental and social situations of the family; 
furthermore the pediatrician can provide indications regarding 
medical education, he should also anticipate possible problems 
and perform preventive actions (13, 26). 
For this he must be familiar with the syndrome having knowl-
edge of the course, of possible complications, of emergencies 
and also the handling of the devices such as percutaneous en-
doscopic gastrostomy feeding, central line or tracheostomy (55, 
56). The doctor should guarantee the correct nutritional intake 
of the child, by monitoring the intake of calories, the growth 
parameters and evaluating the possible vitamins and electrolytic 
same guidance of the healthy children (58). Due to the risk 
of a possible impaired food deglutition the pediatrician must 
begin a rehabilitation or a medical therapy, before directing the 
child to a specialist (12). The sleeping habits must be evaluated 
in order to direct the child to a specialist to solve problems (59).
Vaccinations must be done also on disabled children be-
cause they are more exposed to respiratory diseases, even if 
the vaccines coverage today is very low in this children (17). 
Finally, the pediatrician must assess if the family receive a 
proper social support, discover if the child is harmoniously 
integrated in the school environment, if he his carrying out 
his rehabilitation and if there is interaction between the facili-
ties that assist him (12, 26). The pediatrician must guarantee 
the emergency’s handling of the child with syndrome. This 
because these children enter the emergency room twice more 
than healthy children and are hospitalized much more easily 
(60). At the base of this, on one hand, there is the mistrust of the 
families towards the local clinics, but on the other hand, also 
the pediatrician is concerned about the fragility of the child. 
Therefore, the knowledge of the course of the syndrome 
could facilitate the diagnosis of the complications and limit 
hospitalization to really deserving cases. In some of these 
immediate diagnosis such as chest pain in a boy with Marfan 
syndrome to suggest a pneumothorax or aortic dissection 
(38). While the abdominal pain in Williams syndrome should 
suggest an intestinal or a bladder diverticulitis or a mesenteric 
ischemia. On the contrary, in the Cornelia de Lange syndrome 
could suggest a volvulus due to intestinal malrotation and in 
Ehlers Danlos syndrome could indicate an intestinal rupture 
(9, 35). For example the headache in Williams syndrome and 
-
tensive crisis or a cerebral stroke; while the sudden hypotonia/
hemiplegia in Down syndrome, achondroplasia and in the 
mucopolysaccharidosis must orient towards a trunk-encephalic 
compression from atlanto-axial instability (8, 35, 52, 61). 
CONCLUSION
Even if the child with a malformative syndrome could not 
fully recovered, thanks to the abilities of the pediatrician he 
can be cured in the best way possible to improve the quality 
of the patient life and also for potentiating the child social 
integration (13). 
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